Deep, targeted following-technology sequencing has disclosed that subclonal mutations (i.e., People present in only a fraction of tumor cells) can be detected for all driver genes and are related to fast condition progression and lousy result.11–13 This is especially relevant for TP53 mutations given The point that, as stated down below, CLL ther